Lina Wu Selected Research

Neoplasm Metastasis (Metastasis)

1/2022	MiR-224 promotes lymphatic metastasis by targeting ANGPTL1 in non-small-cell lung carcinoma.
1/2022	Downregulation of long noncoding RNA HCP5/miR-216a-5p/ZEB1 axis inhibits the malignant biological function of laryngeal squamous cell carcinoma cells.
1/2018	MicroRNA-194 regulates cell viability and apoptosis by targeting CDH2 in prostatic cancer.
6/2017	Circulating microRNA-422a is associated with lymphatic metastasis in lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lina Wu Research Topics

Disease

44	Neoplasms (Cancer) 01/2024 - 01/2010
11	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023 - 09/2012
9	Lung Neoplasms (Lung Cancer) 12/2023 - 01/2015
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 01/2018
7	Mitochondrial Diseases (Mitochondrial Disease) 12/2023 - 09/2015
6	Inflammation (Inflammations) 05/2024 - 04/2016
6	Hepatitis B 12/2023 - 01/2020
6	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 02/2013
5	Obesity 01/2024 - 01/2018
5	Infections 06/2023 - 06/2016
4	Wounds and Injuries (Trauma) 05/2024 - 07/2019
4	Membranous Glomerulonephritis (Membranous Nephropathy) 12/2023 - 01/2020
4	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2018
4	Breast Neoplasms (Breast Cancer) 06/2022 - 01/2016
4	Stomach Neoplasms (Stomach Cancer) 01/2022 - 04/2014
4	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2017
4	Type 2 Diabetes Mellitus (MODY) 01/2020 - 11/2014
4	Hyperglycemia 01/2017 - 09/2015
3	COVID-19 03/2024 - 01/2021
3	Proteinuria 12/2023 - 09/2015
3	Fibrosis (Cirrhosis) 12/2023 - 01/2021
3	Thyroid Neoplasms (Thyroid Cancer) 01/2023 - 11/2018
2	Liver Diseases (Liver Disease) 12/2023 - 01/2023
2	Acute Lung Injury 12/2023 - 12/2019
2	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 01/2018
2	Renal Cell Carcinoma (Grawitz Tumor) 05/2023 - 01/2022
2	End Stage Liver Disease 01/2023 - 06/2022
2	Critical Illness (Critically Ill) 01/2023 - 12/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 10/2020
2	Iron Overload 01/2022 - 01/2021
2	Lymphatic Metastasis 01/2022 - 06/2017
2	Osteoporosis 01/2022 - 03/2015
2	Chronic Hepatitis B 10/2021 - 01/2021
2	Common Cold 05/2021 - 07/2014
2	Pneumonia (Pneumonitis) 08/2020 - 04/2020
2	Disease Progression 01/2020 - 01/2019
2	Hyperbilirubinemia 01/2020 - 11/2018
2	Chronic Idiopathic Jaundice (Dubin Johnson Syndrome) 01/2020 - 11/2018
2	Melanoma (Melanoma, Malignant) 01/2019 - 08/2017
2	Carcinogenesis 01/2019 - 08/2017
1	Substance-Related Disorders (Drug Abuse) 04/2024

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 12/2023 - 11/2014
10	Biomarkers (Surrogate Marker)IBA 12/2023 - 04/2014
7	Long Noncoding RNAIBA 01/2023 - 01/2019
6	FluorocarbonsIBA 12/2023 - 01/2018
6	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2016
6	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 11/2014
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 09/2012
4	IronIBA 01/2023 - 01/2021
4	Anti-Bacterial Agents (Antibiotics)IBA 02/2022 - 11/2005
4	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2014
3	HydrogelsIBA 05/2024 - 11/2019
3	Interleukin-6 (Interleukin 6)IBA 03/2024 - 03/2015
3	Therapeutic UsesIBA 10/2023 - 06/2015
3	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2023 - 01/2020
3	Immunoglobulin G (IgG)IBA 01/2023 - 04/2020
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2023 - 06/2022
3	CytokinesIBA 01/2023 - 03/2015
3	Indicators and Reagents (Reagents)IBA 10/2022 - 11/2014
3	CarbonIBA 01/2022 - 04/2007
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2018
3	Adenosine Triphosphate (ATP)IBA 01/2021 - 11/2018
2	AntioxidantsIBA 05/2024 - 10/2023
2	Interleukin-2 (IL2)IBA 03/2024 - 03/2015
2	Interleukin-10 (Interleukin 10)IBA 03/2024 - 03/2015
2	ProteomeIBA 12/2023 - 01/2020
2	ErbB Receptors (EGF Receptor)IBA 12/2023 - 01/2021
2	EndotoxinsIBA 12/2023 - 12/2019
2	Caspase 3 (Caspase-3)IBA 10/2023 - 01/2015
2	AlbuminsIBA 04/2023 - 11/2014
2	CollagenIBA 01/2023 - 01/2021
2	LigandsIBA 01/2023 - 01/2020
2	NitrogenIBA 01/2023 - 07/2019
2	Glycoproteins (Glycoprotein)IBA 01/2023 - 01/2016
2	CreatinineIBA 06/2022 - 11/2014
2	Tyrosine Kinase InhibitorsIBA 05/2022 - 01/2021
2	anilinoquinazolineIBA 05/2022 - 01/2021
2	C-Reactive ProteinIBA 03/2022 - 05/2018
2	Bile Acids and Salts (Bile Acids)IBA 01/2022 - 12/2019
2	Testosterone (Sustanon)FDA Link 11/2021 - 04/2016
2	Antiviral Agents (Antivirals)IBA 10/2021 - 10/2021
2	Multidrug Resistance-Associated Protein 2IBA 01/2020 - 11/2018
2	Small Interfering RNA (siRNA)IBA 12/2019 - 08/2017
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 12/2018 - 01/2015
2	LipidsIBA 05/2018 - 01/2018
2	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2016 - 10/2015
2	ElementsIBA 01/2014 - 07/2010
2	ResveratrolIBA 01/2014 - 09/2012
1	Cocaine (Cocaine HCl)IBA 04/2024

Therapy/Procedure

21	Therapeutics 10/2023 - 03/2015
5	Bariatric Surgery 01/2023 - 01/2018
5	Drug Therapy (Chemotherapy) 01/2023 - 01/2015
4	Gastrectomy 01/2024 - 01/2020
4	Precision Medicine 12/2022 - 03/2018
3	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2022 - 01/2020
2	Immunotherapy 11/2023 - 01/2023
2	Radiotherapy 10/2023 - 01/2015
2	Critical Care (Surgical Intensive Care) 01/2023 - 01/2023
2	Photochemotherapy (Photodynamic Therapy) 12/2022 - 06/2022
2	Quantum Dots (Quantum Dot) 01/2022 - 07/2019